#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Proteus syndrome Chronic kidney disease Neuropathic arthropathy Immunodeficiency common variable Autologous haematopoietic stem cell transplant White matter lesion Dementia Neonatal asphyxia Myxofibrosarcoma Ewing's sarcoma recurrent Neuropathy peripheral Endocrine ophthalmopathy Chronic hepatitis B Cytokine release syndrome Immunodeficiency congenital More trials…

    Learn about Rare Diseases

    Tuberous sclerosis complex – Basic Information Hairy cell leukaemia recurrent – Treatment Undifferentiated sarcoma – Treatment Amyotrophic lateral sclerosis – Basic Information Netherton’s syndrome – Diagnostics Pulmonary fibrosis – Treatment Mastocytosis – Basic Information Noonan syndrome Marginal zone lymphoma – Diagnostics Erdheim-Chester disease – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Caba-201 Mk-0616 13N-AMMONIA Bromhexine Hydrochloride Erenumab Rezpegaldesleukin Regn7508 Landiolol Hydrochloride Mepacrine Rifamycin Sodium Propranolol Rifapentine Oxybutynin Imidapril Hydrochloride Bt8009 Belatacept Pimecrolimus Eculizumab Cetrelimab Enlicitide Chloride More therapies…

    Learn about Your Condition

    Hyperthyroidism Epstein-Barr virus infection Penile cancer Vitamin D deficiency Renal failure Aortic valve stenosis Appendicitis Pneumothorax Deafness bilateral Ophthalmoplegia Menopausal symptoms Mitral valve prolapse Coronary artery bypass Colorectal adenoma Lumbosacral radiculopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Post-acute COVID-19 syndrome

  • Study on the Effects and Safety of Ginkgo Biloba Extract in Patients with Cognitive Impairment After COVID-19

    Not recruiting

    2 1 1
    Germany Poland Spain

  • Study of Plitidepsin Treatment for Adults with Post-COVID-19 Condition

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Post-acute COVID-19 syndrome
    Investigated Drugs:
    • Dexchlorpheniramine
    • Plitidepsin
    • Dexamethasone Phosphate
    Spain

  • Study of Pregabalin Treatment and Rehabilitation for Chronic Fatigue in Post-COVID Syndrome Patients

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Chronic fatigue syndrome
    • Post-acute COVID-19 syndrome
    Investigated Drugs:
    • Pregabalin
    Poland

  • Study of Vericiguat to improve physical function in patients with Post-COVID-19 syndrome with or without chronic fatigue syndrome

    Not recruiting

    2 1
    Investigated Diseases:
    • Post-acute COVID-19 syndrome
    Investigated Drugs:
    • Vericiguat
    Germany

  • Study on the Effects of Vidofludimus Calcium for Patients with Post-COVID Syndrome

    Not recruiting

    2 1
    Investigated Diseases:
    • Post-acute COVID-19 syndrome
    Investigated Drugs:
    • Vidofludimus Calcium
    Germany

  • Study on Methylprednisolone for Improving Memory in Patients with Post-COVID-19 Syndrome

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Post-acute COVID-19 syndrome
    Investigated Drugs:
    • Methylprednisolone
    • Placebo
    Germany
Previous Page
1 2 3

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!